A detailed history of Harbour Investments, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 20,444 shares of MRK stock, worth $2.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
20,444
Previous 20,721 1.34%
Holding current value
$2.4 Million
Previous $2.73 Million 7.46%
% of portfolio
0.09%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$123.8 - $132.96 $34,292 - $36,829
-277 Reduced 1.34%
20,444 $2.53 Million
Q1 2024

Jul 22, 2024

SELL
$113.24 - $131.95 $49,146 - $57,266
-434 Reduced 2.05%
20,721 $2.73 Million
Q4 2023

Feb 16, 2024

BUY
$100.18 - $109.02 $144,159 - $156,879
1,439 Added 7.3%
21,155 $2.31 Million
Q3 2023

Nov 15, 2023

BUY
$102.95 - $114.33 $27,281 - $30,297
265 Added 1.36%
19,716 $2.03 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $140,649 - $153,302
-1,295 Reduced 6.24%
19,451 $2.24 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $14,926 - $16,654
-145 Reduced 0.69%
20,746 $2.21 Million
Q4 2022

Feb 15, 2023

BUY
$87.44 - $112.11 $447,255 - $573,442
5,115 Added 32.42%
20,891 $2.32 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $119,724 - $135,713
1,434 Added 10.0%
15,776 $1.44 Million
Q4 2021

Feb 16, 2022

SELL
$72.28 - $90.54 $1.12 Million - $1.4 Million
-15,439 Reduced 51.84%
14,342 $1.1 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $121,999 - $134,168
1,702 Added 6.06%
29,781 $2.24 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $55,966 - $61,904
796 Added 2.92%
28,079 $2.18 Million
Q1 2021

Aug 17, 2021

BUY
$68.86 - $81.11 $1.78 Million - $2.1 Million
25,832 Added 1780.29%
27,283 $2.1 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $99,915 - $117,690
1,451 New
1,451 $112,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $297B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.